Literature DB >> 25332971

Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.

Antonio Franchitto1, Paolo Onori1, Anastasia Renzi1, Guido Carpino1, Romina Mancinelli1, Domenico Alvaro1, Eugenio Gaudio1.   

Abstract

Cholangiocytes are epithelial cells lining the biliary epithelium. Cholangiocytes play several key roles in the modification of ductal bile and are also the target cells in chronic cholestatic liver diseases (i.e., cholangiopathies) such as PSC, PBC, polycystic liver disease (PCLD) and cholangiocarcinoma (CCA). During these pathologies, cholangiocytes (which in normal condition are in a quiescent state) begin to proliferate acquiring phenotypes of neuroendocrine cells, and start secreting different cytokines, growth factors, neuropeptides, and hormones to modulate cholangiocytes proliferation and interaction with the surrounding environment, trying to reestablish the balance between proliferation/loss of cholangiocytes for the maintenance of biliary homeostasis. The purpose of this review is to summarize the recent findings on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology. To clarify the mechanisms of action of these factors we will provide new potential strategies for the management of chronic liver diseases.

Entities:  

Keywords:  Biliary tree; cholangiocytes; liver; neuroendocrine regulation; proliferation

Year:  2013        PMID: 25332971      PMCID: PMC4200672          DOI: 10.3978/j.issn.2305-5839.2012.10.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  108 in total

1.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

2.  Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line.

Authors:  D M Harnois; F G Que; A Celli; N F LaRusso; G J Gores
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

3.  A morphometric study of the epithelium lining the rat intrahepatic biliary tree.

Authors:  A Benedetti; C Bassotti; K Rapino; L Marucci; A M Jezequel
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

Review 4.  Current problems in diagnosis of biliary disease and cholestasis.

Authors:  V J Desmet
Journal:  Semin Liver Dis       Date:  1986-08       Impact factor: 6.115

5.  Histopathology of vanishing bile duct diseases.

Authors: 
Journal:  Adv Clin Path       Date:  1998-04

6.  A scanning electron microscopic study of liver microcirculation disarrangement in experimental rat cirrhosis.

Authors:  E Gaudio; L Pannarale; P Onori; O Riggio
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

7.  After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.

Authors:  Romina Mancinelli; Antonio Franchitto; Eugenio Gaudio; Paolo Onori; Shannon Glaser; Heather Francis; Julie Venter; Sharon Demorrow; Guido Carpino; Shelley Kopriva; Mellanie White; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

8.  Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

Authors:  Paolo Onori; Sharon DeMorrow; Eugenio Gaudio; Antonio Franchitto; Romina Mancinelli; Julie Venter; Shelley Kopriva; Yoshiyuki Ueno; Domenico Alvaro; Jennifer Savage; Gianfranco Alpini; Heather Francis
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

9.  Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy.

Authors:  H Kirimlioglu; A Ecevit; S Yilmaz; V Kirimlioglu; A Bay Karabulut
Journal:  Transplant Proc       Date:  2008 Jan-Feb       Impact factor: 1.066

10.  Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.

Authors:  Shannon Glaser; Domenico Alvaro; Tania Roskams; Jo Lynne Phinizy; George Stoica; Heather Francis; Yoshiyuki Ueno; Barbara Barbaro; Marco Marzioni; Jeremy Mauldin; Sobia Rashid; Maria Grazia Mancino; Gene LeSage; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-12-27       Impact factor: 4.052

View more
  22 in total

Review 1.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

Review 2.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

3.  CCN1 induces hepatic ductular reaction through integrin αvβ₅-mediated activation of NF-κB.

Authors:  Ki-Hyun Kim; Chih-Chiun Chen; Gianfranco Alpini; Lester F Lau
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

4.  Lung protective effects of budesonide nebulization during perioperative period of thoracolumbar fusion.

Authors:  Wenjing Li; Yu Zhao; Zhijian Sun; Xu Yang; Lijuan Zhao; Jianxiong Shen
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

5.  Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.

Authors:  Matthew McMillin; Sharon DeMorrow; Shannon Glaser; Julie Venter; Konstantina Kyritsi; Tianhao Zhou; Stephanie Grant; Thao Giang; John F Greene; Nan Wu; Brandi Jefferson; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-27       Impact factor: 4.052

6.  Low bone mineral density is associated with increased arterial stiffness in participants of a health records based study.

Authors:  Ya-Qin Wang; Ping-Ting Yang; Hong Yuan; Xia Cao; Xiao-Ling Zhu; Guo Xu; Zhao-Hui Mo; Zhi-Heng Chen
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 7.  ADPKD: clinical issues before and after renal transplantation.

Authors:  Piergiorgio Messa; Carlo Maria Alfieri; Emanuele Montanari; Mariano Ferraresso; Roberta Cerutti
Journal:  J Nephrol       Date:  2016-10-20       Impact factor: 3.902

8.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

9.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

10.  Inhibition of the liver expression of arylalkylamine N-acetyltransferase increases the expression of angiogenic factors in cholangiocytes.

Authors:  Anastasia Renzi; Romina Mancinelli; Paolo Onori; Antonio Franchitto; Gianfranco Alpini; Shannon Glaser; Eugenio Gaudio
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.